Brought to you by 
Pharmacia & Upjohn's Biacore AB subsidiary goes public
13 Jul 1999
Executive Summary
Pharmacia & Upjohn has spun off a portion of its stake in its wholly-owned Swiss subsidiary, Biacore AB, through an initial public offering of 5mm American Depository Shares or ordinary shares priced at $16 (SEK106.75)per share.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Biosensors
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pharmacia & Upjohn's Biacore AB subsidiary goes public
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice